事件追踪 · 持续 2 天

US — Merck and Moderna announce positive melanoma vaccine trial results

Moderna and Merck announce Intismeran, an mRNA-based cancer vaccine · Intismeran reduces melanoma recurrence and spread in late-stage trials · Interim results show treatment met goals of reducing cancer recurrence and spread

首次出现 2026 年 8 月 20 日 · 最近更新 2026 年 8 月 21 日 · 2 条记录 · 2 期简报

1. 8 月 21 日

   US — Merck and Moderna announce positive melanoma vaccine trial results

   Moderna and Merck announce Intismeran, an mRNA-based cancer vaccine · Intismeran reduces melanoma recurrence and spread in late-stage trials · Interim results show treatment met goals of reducing cancer recurrence and spread

   第 68 期
2. 8 月 20 日

   Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

   Moderna and Merck announce Intismeran, an mRNA-based cancer vaccine · Intismeran reduces melanoma recurrence and spread in late-stage trials · Interim results show treatment met goals of reducing cancer recurrence and spread

   第 67 期